1
PATENT ABSTRACTS 77 ~8M12 4783524 HYBRID DNA SYNTHESIS OF EPIDERMAL GROWTH FACTOR GROWTH FACTORS Graeme I Bell assigned to Chiron Corporation DNA sequences and methods of obtaining DNA sequences which include a sequence encoding for mammalian epidermal growth fac- tor are provided. The DNA sequences may be used in cloning and expression vectors for pro- duction of DNA and RNA and for producing polypeptides including mammalian epidermal growth factor. E. coli strains HB 101 (pmegfl) and HB 101 (pmegfl0b), and bacteriophage lam- bdahEGF34 were deposited at the A.T.C.C. on May 10, 1983 and given Accession Nos. 39357, 39358 and 40070, respectively. Brent R Larsen, Ned Siegel, Claire E Kotts, Michael F McGrath, Sharon D Ogden, Gwen Krivi, John Minnerly assigned to Monsanto Company This invention relates to novel peptides having utility for promotion of growth and/or lactation in animals, to processes and DNA useful in pro- duction of such peptides, and to methods utilizing such peptides to promote growth or lac- tation in animals. In some embodiments, the in- vention is directed to peptides having bovine IGF-II biological activity, to production of such peptides, and to their use in effecting prolifera- tion of certain cells (e.g. mammary epithelial or muscle) or in enhancing lactation in cattle or other animals. 4783415 GENE CODING FOR SIGNAL PEPTIDES AND UTILIZATION THEREOF Shiger Hoshiko, Osamu Makabe, Shunzo Fukatsu, Kozo Nagaoka, Yokohama, Japan as- signed to Meiji Seika Kabushiki Kaisha A DNA segment of a gene coding for a signal peptide is disclosed the segment is to be used in a host-vector system employing a bacterium belonging to the genus Streptomyces as a host by incorporation in the vector DNA. The segment comprises a DNA having a base sequence coding for the peptide having the amino acid sequence from X to Y in the annexed FIG. 1. A vector plasmid to be used for transformation of bac- teria belonging to the genus Streptomyces is also disclosed. The plasmid comprises a DNA seg- ment with a base sequence coding for an extra- cellular alpha-amylase derived from Streptomyces hygroscopicus SF-1084 strain or a mutant thereof the DNA segment incorporated into a vector plasmid is to be used in a host- vector system employing a bacterium belonging to the genus Streptomyces as a host and also having a DNA segment necessary for expression of the gene information of the DNA segment. The present invention may be applied to the pro- duction of a desired protein which will be secreted outside the host microorganism.. 4753798 METHODS AND COMPOSITIONS FOR CONTROLLING PROTOZOAL INFECTIONS IN WARM-BLOODED ANIMALS Sidne Kantor, Robert L Kennett assigned to American Cyanamid Company This invention relates to methods and composi- tions for the control of protozoal infections in warm-blooded animals by administering to said animals a protozoacidally-effective amount of a new antibiotic designated LL-E19020 alpha, LL- E19020 beta or a pharmaceutically and pro- phylactically acceptable salt thereof. The new antibiotics are produced by microbiological fer- mentation under controlled conditions using a new strain of Streptomyces lydicus subspecies tanzanius or mutants thereof.

4783524 Growth factors

Embed Size (px)

Citation preview

PATENT ABSTRACTS 77

~ 8 M 1 2 4783524

H Y B R I D D N A S Y N T H E S I S O F E P I D E R M A L G R O W T H F A C T O R

G R O W T H F A C T O R S

Graeme I Bell assigned to Chiron Corporation

DNA sequences and methods of obtaining DNA sequences which include a sequence encoding for mammalian epidermal growth fac- tor are provided. The DNA sequences may be used in cloning and expression vectors for pro- duction of DNA and RNA and for producing polypeptides including mammalian epidermal growth factor. E. coli strains HB 101 (pmegfl) and HB 101 (pmegfl0b), and bacteriophage lam- bdahEGF34 were deposited at the A.T.C.C. on May 10, 1983 and given Accession Nos. 39357, 39358 and 40070, respectively.

Brent R Larsen, Ned Siegel, Claire E Kotts, Michael F McGrath, Sharon D Ogden, Gwen Krivi, John Minnerly assigned to Monsanto Company

This invention relates to novel peptides having utility for promotion of growth and/or lactation in animals, to processes and DNA useful in pro- duction of such peptides, and to methods utilizing such peptides to promote growth or lac- tation in animals. In some embodiments, the in- vention is directed to peptides having bovine IGF-II biological activity, to production of such peptides, and to their use in effecting prolifera- tion of certain cells (e.g. mammary epithelial or muscle) or in enhancing lactation in cattle or other animals.

4783415

G E N E C O D I N G F O R S I G N A L P E P T I D E S A N D U T I L I Z A T I O N

T H E R E O F

Shiger Hoshiko, Osamu Makabe, Shunzo Fukatsu, Kozo Nagaoka, Yokohama, Japan as- signed to Meiji Seika Kabushiki Kaisha

A DNA segment of a gene coding for a signal peptide is disclosed the segment is to be used in a host-vector system employing a bacterium belonging to the genus Streptomyces as a host by incorporation in the vector DNA. The segment comprises a DNA having a base sequence coding for the peptide having the amino acid sequence from X to Y in the annexed FIG. 1. A vector plasmid to be used for transformation of bac- teria belonging to the genus Streptomyces is also disclosed. The plasmid comprises a DNA seg- ment with a base sequence coding for an extra- cellular alpha-amylase derived from Streptomyces hygroscopicus SF-1084 strain or a mutant thereof the DNA segment incorporated into a vector plasmid is to be used in a host- vector system employing a bacterium belonging to the genus Streptomyces as a host and also having a DNA segment necessary for expression of the gene information of the DNA segment. The present invention may be applied to the pro- duction of a desired protein which will be secreted outside the host microorganism..

4753798

M E T H O D S A N D C O M P O S I T I O N S F O R C O N T R O L L I N G

P R O T O Z O A L I N F E C T I O N S I N W A R M - B L O O D E D A N I M A L S

Sidne Kantor, Robert L Kennett assigned to American Cyanamid Company

This invention relates to methods and composi- tions for the control of protozoal infections in warm-blooded animals by administering to said animals a protozoacidally-effective amount of a new antibiotic designated LL-E19020 alpha, LL- E19020 beta or a pharmaceutically and pro- phylactically acceptable salt thereof. The new antibiotics are produced by microbiological fer- mentation under controlled conditions using a new strain of Streptomyces lydicus subspecies tanzanius or mutants thereof.